Eczema Press Articles

Business Wire - Meda Expands Presence in Asia

April 3, 2012 --

GOTEBORG, Sweden -- Regulatory News:

Meda (STO:MEDAA) has established an affiliate in Hong Kong. At the end of last year, Meda opened...

continue reading

Reference & Research Book News - The allergy epidemic; a mystery of modern life

April 1, 2012 --

The allergy epidemic; a mystery of modern life.

Prescott, Susan.

UWA

2011

275 pages

$29.95

...

continue reading

Chain Drug Review - Poison ivy spray eases application

March 26, 2012 --

FAIRFIELD, N.J. -- Ivy-Dry Inc. has introduced what it says is the only continuous-spray poison ivy treatment.

The newest Ivy-Dry...

continue reading

Market Wire - Caring for Problem Skin

March 8, 2012 --

(Family Features) According to the National Institutes of Health, skin is the largest organ of your body. Skin can be a very delicate thing,...

continue reading

Market Wire - Beauty's Top 100 Articles of the Year: Skincare-News.com Guide to the Year's Top Articles on Skincare, Hair, Fashion and Lifestyle

March 5, 2012 --

Everyone can use a little help turning beauty goals into reality. Skincare-News.com offers a guide to all beauty-related issues, whether a...

continue reading

Market Wire - Onset Dermatologics Launches Aurstat(R) Kit

February 28, 2012 --

Onset Dermatologics, a PreCision Dermatology company and a leader in developing and commercializing novel, prescription products for...

continue reading

Evening Chronicle (Newcastle, England) - Skin is under attack; THINK PHARMACY FIRST

February 27, 2012 --

Byline: Omar Ahmad

Skin is under attack OUR skin is open to attack by so many everyday items, and that is why sometimes it becomes...

continue reading

Business Wire - Research and Markets: Eczema Therapeutics Market is Forecast to Show Significant Growth until 2018

January 12, 2012 --

DUBLIN -- Research and Markets (

continue reading

Market Wire - Basilea to file application for marketing authorization of ceftobiprole for the treatment of pneumonia

January 5, 2012 --

Basilea Pharmaceutica AG /

Basilea to file application for marketing authorization of ceftobiprole forthetreatment of pneumonia...

continue reading

Market Wire - Biomerica Launches New Patented Test to Identify Individuals at Risk of Developing Severe Side Effects From Thiopurine Drugs

January 1, 2012 --

Biomerica, Inc. (OTCBB: BMRA) announced that it has launched a new patented Thiopurine methyltransferase (TPMT) test to detect patients who...

continue reading